Form 20FR12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001193125-12-145411
Filing Date
2012-04-02
Accepted
2012-04-02 12:20:59
Documents
14

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO REGISTRATION STATEMENT ON FORM 20-F d250851d20fr12ba.htm 20FR12B/A 2834133
2 DEPOSIT AGREEMENT d250851dex21.htm EX-2.1 289827
3 AGREEMENT d250851dex419.htm EX-4.19 159897
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d250851dex151.htm EX-15.1 2954
5 LETTER REGARDING CHANGE IN CERTIFYING ACCOUNTANT d250851dex161.htm EX-16.1 2944
7 GRAPHIC g250851ex15_1pg1a.jpg GRAPHIC 9617
8 GRAPHIC g250851ex15_1pg1b.jpg GRAPHIC 3212
9 GRAPHIC g250851ex15_1pg1c.jpg GRAPHIC 2993
10 GRAPHIC g250851ex15_1pg1d.jpg GRAPHIC 35269
11 GRAPHIC g250851ex16_1pg1a.jpg GRAPHIC 9845
12 GRAPHIC g250851ex16_1pg1b.jpg GRAPHIC 2994
13 GRAPHIC g250851ex16_1pg1c.jpg GRAPHIC 43338
14 GRAPHIC g250851g79u35.jpg GRAPHIC 1982
15 filename15.htm CORRESP 10222
  Complete submission text file 0001193125-12-145411.txt   3452745
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

State of Incorp.: C3
Type: 20FR12B/A | Act: 34 | File No.: 001-35428 | Film No.: 12732055
SIC: 2834 Pharmaceutical Preparations